Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
Veterinary World
|
August 14, 2023
West Nile virus: The current situation in Egypt
Rabab T Hassanien, Heba A Hussein, Hala K Abdelmegeed, et al.
Biomed Research International
|
June 3, 2022
Phytochemistry and Biological Properties of <i>Salvia verbenaca</i> L.: A Comprehensive Review
Hanae Naceiri Mrabti, Naoual El Menyiy, Saoulajan Charfi, et al.
Scientific Reports
|
July 17, 2025
Deep learning models for deriving optimised measures of fat and muscle mass from MRI
Belvin Thomas, M Adam Ali, Fatima M H Ali, et al.
Bioorganic Chemistry
|
October 19, 2019
Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors
Mohammed S Abdel-Maksoud, Usama M Ammar, Mohammed I El-Gamal, et al.
Bioorganic & Medicinal Chemistry
|
January 10, 2021
Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor
Eslam M H Ali, Mohammed S Abdel-Maksoud, Rasha Mohamed Hassan, et al.
Ebiomedicine
|
February 1, 2025
Comparison of autism domains across thirty rare variant genotypes
Nabila M H Ali, Samuel J R A Chawner, Leila Kushan-Wells, et al.
Osteoarthritis and Cartilage
|
June 29, 2015
Characterization of degenerative human facet joints and facet joint capsular tissues
J-S Kim, M H Ali, F Wydra, et al.
Veterinary World
|
August 25, 2023
Circulating foot-and-mouth disease virus serotype A African-genotype IV in Egypt during 2022
Momtaz A Shahein, Heba A Hussein, M H Ali, et al.
European Journal of Medicinal Chemistry
|
February 18, 2021
Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAF<sup>V600E</sup>/p38α inhibitors
Eslam M H Ali, Rania Farag A El-Telbany, Mohammed S Abdel-Maksoud, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 7, 2022
Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAF<sup>V600E</sup>/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study
Eslam M H Ali, Karim I Mersal, Usama M Ammar, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
Veterinary World
|
August 14, 2023
West Nile virus: The current situation in Egypt
Rabab T Hassanien, Heba A Hussein, Hala K Abdelmegeed, et al.
Biomed Research International
|
June 3, 2022
Phytochemistry and Biological Properties of <i>Salvia verbenaca</i> L.: A Comprehensive Review
Hanae Naceiri Mrabti, Naoual El Menyiy, Saoulajan Charfi, et al.
Scientific Reports
|
July 17, 2025
Deep learning models for deriving optimised measures of fat and muscle mass from MRI
Belvin Thomas, M Adam Ali, Fatima M H Ali, et al.
Bioorganic Chemistry
|
October 19, 2019
Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors
Mohammed S Abdel-Maksoud, Usama M Ammar, Mohammed I El-Gamal, et al.
Bioorganic & Medicinal Chemistry
|
January 10, 2021
Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor
Eslam M H Ali, Mohammed S Abdel-Maksoud, Rasha Mohamed Hassan, et al.
Ebiomedicine
|
February 1, 2025
Comparison of autism domains across thirty rare variant genotypes
Nabila M H Ali, Samuel J R A Chawner, Leila Kushan-Wells, et al.
Osteoarthritis and Cartilage
|
June 29, 2015
Characterization of degenerative human facet joints and facet joint capsular tissues
J-S Kim, M H Ali, F Wydra, et al.
Veterinary World
|
August 25, 2023
Circulating foot-and-mouth disease virus serotype A African-genotype IV in Egypt during 2022
Momtaz A Shahein, Heba A Hussein, M H Ali, et al.
European Journal of Medicinal Chemistry
|
February 18, 2021
Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAF<sup>V600E</sup>/p38α inhibitors
Eslam M H Ali, Rania Farag A El-Telbany, Mohammed S Abdel-Maksoud, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 7, 2022
Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAF<sup>V600E</sup>/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study
Eslam M H Ali, Karim I Mersal, Usama M Ammar, et al.
Page
of 11